FDA.reportPublic FDA data

Application 204512

Type
ANDA
Sponsor
NCM USA BRONX LLC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001FLUDEOXYGLUCOSE F18FLUDEOXYGLUCOSE F-18INJECTABLE;INTRAVENOUS20-300mCi/MLNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
24445-334Fludeoxyglucose F 18Fludeoxyglucose F 18NCM-USA Bronx LLCANDACurrent
24445-334Fludeoxyglucose F 18Fludeoxyglucose F 18NCM-USA Bronx LLCANDACurrent
24445-334Fludeoxyglucose F 18Fludeoxyglucose F 18NCM-USA Bronx LLCANDACurrent
24445-334Fludeoxyglucose F 18Fludeoxyglucose F 18NCM-USA Bronx LLCANDACurrent
24445-334Fludeoxyglucose F 18Fludeoxyglucose F 18NCM-USA Bronx LLCANDACurrent